Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lessons learned from a multiple-dose post-operative analgesic trial.

Tito R Mendoza1, Connie Chen, Andrew Brugger

  • 1Pain Research Group, Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 221, Houston, TX 77030, USA. tmendoza@mdanderson.org

Pain
|April 15, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Treatment outcomes with palbociclib plus an aromatase inhibitor in patients with metastatic breast cancer who also have cardiovascular diseases: a plain language summary.

Future oncology (London, England)·2026
Same author

Ontogeny of Placental FcRn Protein During Human and Animal Pregnancy to Inform Developmental Toxicity Testing.

Birth defects research·2026
Same author

Report From the International Conference on Incontinentia Pigmenti: Translating Discovery to Therapy.

American journal of medical genetics. Part A·2026
Same author

Human iPSC-derived macrophages for studying intrinsic and extrinsic factors in cystic fibrosis.

EXO : beyond the cell·2026
Same author

Benchmark Response Values for Error-Corrected Sequencing Mutagenicity Assessment Technologies.

Environmental and molecular mutagenesis·2026
Same author

Understanding the provider experience with digital tools in blended care therapy delivered via telehealth: A mixed-methods evaluation.

Digital health·2026
Same journal

Pain prevalence and intensity in advanced pancreatic cancer: a nationwide cohort study.

Pain·2026
Same journal

Neurobiology of the trigeminal ganglion in comparison to the dorsal root ganglion.

Pain·2026
Same journal

Peripheral kappa opioid receptors modulate cold hypersensitivity in a mouse model of chemotherapy-induced neuropathy.

Pain·2026
Same journal

Efficacy and effectiveness of melatonin for the management of musculoskeletal pain: a systematic review and meta-analysis of placebo and active controlled trials.

Pain·2026
Same journal

Predictive socio-cultural factors of pain intensity, disability, and quality of life in patients with nonspecific musculoskeletal pain: a prospective cohort study.

Pain·2026
Same journal

Reward-induced endogenous pain inhibition scales with action-outcome certainty in humans.

Pain·2026
See all related articles

Post-operative pain after major surgery can be categorized as mild, moderate, or severe. Most patients experience mild pain by day 6, suggesting focused clinical trials for persistent moderate-to-severe pain.

Area of Science:

  • Pain Management
  • Clinical Trials
  • Surgical Outcomes

Background:

  • Major surgery necessitates extended post-operative pain management.
  • Limited data exist on the trajectory of post-operative pain.
  • Understanding pain patterns aids treatment planning and clinical trial design.

Purpose of the Study:

  • Categorize post-operative pain severity using the Brief Pain Inventory (BPI).
  • Examine the correlation between BPI scores and specific post-sternotomy pain ratings.
  • Assess the relationship between overall medication effectiveness and other pain metrics.

Main Methods:

  • Reanalysis of data from patients undergoing coronary artery bypass graft (CABG) surgery.
  • Utilized a modified Brief Pain Inventory (BPI) for pain assessment.

Related Experiment Videos

  • Compared pain severity classifications for chronic versus post-operative pain.

    • Main Results:

    • Established cut points for mild, moderate, and severe post-operative pain.
    • 18% of patients reported moderate pain on day 3; 14% reported severe pain.
    • Only 9% experienced moderate-to-severe pain by the study's end (approx. 2 weeks).

    Conclusions:

    • The BPI classification system effectively categorizes post-operative pain.
    • Classifying pain severity offers a meaningful clinical trial outcome measure.
    • Future post-operative pain trials could be more efficient by focusing on patients with persistent moderate-to-severe pain.